Risk factors associated with chronic obstructive pulmonary disease early readmission

References

• Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006;27:188-207
   PubMed Web of Science ®Google Scholar
• Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412
   PubMed Web of Science ®Google Scholar
• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176:753-60
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65
   PubMed Web of Science ®Google Scholar
• Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet 2009;374:744-55
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52
   PubMed Web of Science ®Google Scholar
• Osman IM, Godden DJ, Friend JA, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67-71
   PubMed Web of Science ®Google Scholar
• Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131:696-704
   PubMed Web of Science ®Google Scholar
• Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003;58:589-93
   PubMed Web of Science ®Google Scholar
• Chenna PR, Mannino DM. Outcomes of severe COPD exacerbations requiring hospitalization. Semin Respir Crit Care Med 2010;31:286-94
   PubMed Web of Science ®Google Scholar
• Oostenbrink JB, Rutten-Van Molken MP. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004;98:883-91
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc 2006;3:619-23
   PubMedGoogle Scholar
• Miravitlles M, Murio C, Guerrero T, et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449-55
   PubMed Web of Science ®Google Scholar
• Nantsupawat T, Limsuwat C, Nugent K. Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chronic Respiratory Disease 2012;9:93-8
   PubMed Web of Science ®Google Scholar
• Liu SF, Lin KC, Chin CH, et al. Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease. Respirology 2007;12:560-5
   PubMed Web of Science ®Google Scholar
• Bahadori K, Fitzgerald JM, Levy RD, et al. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J 2009;16:43-9
   PubMed Web of Science ®Google Scholar
• Bahadori K, Fitzgerald JM. Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review. Int J Chron Obstruct Pulmon Dis 2007;2:241-51
   PubMedGoogle Scholar
• Anderson GF, Steinberg EP. Hospital readmissions in the Medicare population. N Engl J Med 1984;311:1349-53
   PubMed Web of Science ®Google Scholar
• Yang H, Thomas S. Readmission: concept, measurement and policy implications. Chinese Health Quality Management 2009;16:113-15
   Google Scholar
• Thomas JW, Holloway JJ. Investigating early readmission as an indicator for quality of care studies. Med Care 1991;29:377-94
   PubMed Web of Science ®Google Scholar
• Westert GP, Lagoe RJ, Keskimaki I, et al. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002;61:269-78
   PubMed Web of Science ®Google Scholar
• Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med 2000;160:1074-81
   PubMed Web of Science ®Google Scholar
• Chan FW, Wong FY, Yam CH, et al. Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: analysis of hospital admission records. BMC Health Serv Res 2011;11:186
   PubMed Web of Science ®Google Scholar
• Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-28
   PubMed Web of Science ®Google Scholar
• Chen H, Jiao YH, Zhao MG, et al. A comparative analysis of ‘re-entry category’ indicators in five major general hospitals in Beijing. Chinese Health Quality Management 2010;17:4-7
   Google Scholar
• Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100-5
   PubMed Web of Science ®Google Scholar
• Gonzalez C, Servera E, Ferris G, et al. Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease. Arch Bronconeumol 2004;40:502-7
   PubMed Web of Science ®Google Scholar
• Baker EH, Wood DM, Brennan AL, et al. Hyperglycaemia and pulmonary infection. Proc Nutr Soc 2006;65:227-35
   PubMed Web of Science ®Google Scholar
• Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284-9
   PubMed Web of Science ®Google Scholar
• Mcghan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-55
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Q, Johansen H. Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity. Int J Tuberc Lung Dis 2009;13:394-9
   PubMed Web of Science ®Google Scholar
• Similowski T, Agusti A, Macnee W, et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006;27:390-6
   PubMed Web of Science ®Google Scholar
• Martinez-Rivera C, Portillo K, Munoz-Ferrer A, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012;9:243-50
   PubMedGoogle Scholar
• Barba R, De Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor. Curr Med Res Opin 2012;28:617-22
   PubMed Web of Science ®Google Scholar
• Giron R, Matesanz C, Garcia-Rio F, et al. Nutritional state during COPD exacerbation: clinical and prognostic implications. Ann Nutr Metab 2009;54:52-8
   PubMed Web of Science ®Google Scholar
• Alcolea Batres S, Villamor Leon J, Alvarez-Sala R. Nutritional Status in COPD. Arch Bronconeumol 2007;43:283-8
   PubMed Web of Science ®Google Scholar
• Myint PK, Lowe D, Stone RA, et al. U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations. Respiration 2011;82:320-7
   PubMed Web of Science ®Google Scholar
• Roca B, Almagro P, Lopez F, et al. Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments. Intern Emerg Med 2011;6:47-54
   PubMed Web of Science ®Google Scholar